Jounce Therapeutics Price History

JNCEDelisted Stock  USD 1.88  0.00  0.00%   
If you're considering investing in Jounce Stock, it is important to understand the factors that can impact its price. As of today, the current price of Jounce Therapeutics stands at 1.88, as last reported on the 17th of April 2024, with the highest price reaching 1.88 and the lowest price hitting 1.88 during the day. We have found four technical indicators for Jounce Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Jounce Therapeutics' Day Median Price of 1.88, day typical price of 1.88, and Rate Of Daily Change of 1.0 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Jounce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
JNCE
Based on monthly moving average Jounce Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jounce Therapeutics by adding Jounce Therapeutics to a well-diversified portfolio.

Jounce Therapeutics Stock Price History Chart

There are several ways to analyze Jounce Stock price data. The simplest method is using a basic Jounce candlestick price chart, which shows Jounce Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Jounce Stock Price History Data

OpenHighLowCloseVolume
04/17/2024
 1.88  1.88  1.88  1.88 
05/05/2023 1.88  1.88  1.88  1.88  1.00 
05/04/2023 1.88  1.88  1.88  1.88  1.00 
05/03/2023 1.92  1.93  1.88  1.88  11,589,391 
05/02/2023 1.91  1.93  1.91  1.93  2,313,702 
05/01/2023 1.93  1.94  1.91  1.92  1,909,704 
04/28/2023 1.93  1.95  1.92  1.93  628,615 
04/27/2023 1.93  1.95  1.91  1.94  793,994 
04/26/2023 1.94  1.95  1.91  1.93  1,095,113 
04/25/2023 1.93  1.96  1.93  1.93  874,864 
04/24/2023 1.91  1.92  1.90  1.90  242,816 
04/21/2023 1.90  1.92  1.90  1.91  395,689 
04/20/2023 1.90  1.92  1.90  1.91  442,193 
04/19/2023 1.91  1.92  1.90  1.90  385,520 
04/18/2023 1.92  1.94  1.90  1.90  567,643 
04/17/2023 1.90  1.98  1.90  1.92  982,300 
04/14/2023 1.93  1.93  1.89  1.92  830,200 
04/13/2023 1.87  1.94  1.87  1.92  769,510 
04/12/2023 1.87  1.90  1.86  1.89  1,616,142 
04/11/2023 1.87  1.89  1.86  1.87  629,700 
04/10/2023 1.87  1.88  1.86  1.87  1,107,234 
04/06/2023 1.88  1.90  1.86  1.89  691,868 
04/05/2023 1.87  1.90  1.86  1.90  2,184,401 
04/04/2023 1.85  1.88  1.84  1.87  1,429,858 
04/03/2023 1.85  1.86  1.84  1.85  1,228,197 
03/31/2023 1.85  1.86  1.84  1.85  1,040,375 
03/30/2023 1.85  1.87  1.83  1.85  5,371,312 
03/29/2023 1.84  1.86  1.84  1.85  3,350,982 
03/28/2023 1.83  1.85  1.83  1.84  11,195,105 
03/27/2023 1.87  1.90  1.81  1.83  15,863,597 
03/24/2023 1.50  1.52  1.46  1.51  907,418 
03/23/2023 1.52  1.54  1.48  1.52  1,288,352 
03/22/2023 1.59  1.60  1.45  1.48  1,561,458 
03/21/2023 1.67  1.69  1.56  1.59  1,132,176 
03/20/2023 1.65  1.72  1.61  1.67  2,109,647 
03/17/2023 1.55  1.64  1.53  1.61  3,115,055 
03/16/2023 1.43  1.62  1.40  1.56  4,268,418 
03/15/2023 1.46  1.64  1.43  1.49  29,099,397 
03/14/2023 1.02  1.09  0.99  1.06  448,821 
03/13/2023 0.95  1.01  0.94  1.00  667,300 
03/10/2023 1.00  1.04  0.90  0.90  581,598 
03/09/2023 1.08  1.09  0.95  0.96  694,989 
03/08/2023 1.03  1.11  0.92  1.07  1,137,191 
03/07/2023 1.06  1.09  0.99  1.05  827,788 
03/06/2023 1.10  1.11  1.01  1.08  3,066,304 
03/03/2023 1.16  1.19  1.10  1.11  722,833 
03/02/2023 1.11  1.21  1.10  1.16  675,900 
03/01/2023 1.13  1.18  1.10  1.16  1,478,091 
02/28/2023 1.15  1.20  1.09  1.12  2,899,263 
02/27/2023 1.13  1.25  1.13  1.15  3,372,569 
02/24/2023 1.10  1.17  1.04  1.15  3,693,699 
02/23/2023 1.22  1.36  1.09  1.10  42,028,088 
02/22/2023 1.03  1.07  0.98  0.99  268,842 
02/21/2023 1.10  1.18  1.01  1.04  371,704 
02/17/2023 1.09  1.11  1.02  1.10  293,842 
02/16/2023 1.11  1.11  1.08  1.08  190,904 
02/15/2023 1.13  1.14  1.10  1.12  265,800 
02/14/2023 1.12  1.15  1.09  1.12  214,924 
02/13/2023 1.11  1.14  1.08  1.11  175,500 
02/10/2023 1.11  1.15  1.08  1.11  260,300 
02/09/2023 1.20  1.22  1.11  1.11  298,632 

About Jounce Therapeutics Stock history

Jounce Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jounce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jounce Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jounce Therapeutics stock prices may prove useful in developing a viable investing in Jounce Therapeutics
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. Jounce Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 137 people.

Jounce Therapeutics Stock Technical Analysis

Jounce Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Jounce Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Jounce Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Jounce Therapeutics information on this page should be used as a complementary analysis to other Jounce Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Jounce Stock

If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years